Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice

Obesity is a significant risk factor for ovarian cancer (OC) and associated with worse outcomes for this disease. We assessed the anti-tumorigenic effects of metformin in human OC cell lines and a genetically engineered mouse model of high grade serous OC under obese and lean conditions. Metformin p...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jianjun, Wysham, Weiya Z., Zhong, Yan, Guo, Hui, Zhang, Lu, Malloy, Kim M., Dickens, Hallum K., Huh, Gene, Lee, Douglas, Makowski, Liza, Zhou, Chunxiao, Bae-Jump, Victoria L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762298/
https://www.ncbi.nlm.nih.gov/pubmed/29340030
http://dx.doi.org/10.18632/oncotarget.20754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762298/
https://www.ncbi.nlm.nih.gov/pubmed/29340030
http://dx.doi.org/10.18632/oncotarget.20754

Ejemplares similares